XTLB   $2.51  0.80% Market Closed After Close 2.0 -20.32%

XTL Biopharmaceuticals Ltd.

EMA (20): 2026-05-07 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2026-05-07 the price crossed down the moving average line and demonstrates a downside trend.

EMA (100): 2025-10-17 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.

Trend Type flat and down
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -4.87%
EMA (20) date of signal May 7, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -4.87%
EMA (50) date of signal May 7, 2026, 3 a.m.
EMA (100) Signals None
EMA (100) Yield 0.0
EMA (100) date of signal
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal May 22, 2026, 3 a.m.
MACD Signals bearish
MACD Yield -4.51%
MACD date of signal May 18, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 2.01%
Stochastic date of signal May 21, 2026, 3 a.m.
Updated May 22, 2026, 11:02 p.m.